Anzeige
Meldung des Tages: Gold-Aktie vor Neubewertung? Über 200 Meter Gold: Warum diese Aktie jetzt in den Fokus der Profis rückt

DBV Technologies Aktie News

Aktie
WKN:  A1JWB7 ISIN:  FR0010417345 US-Symbol:  DBVTF Branche:  Biotechnologie Land:  Frankreich
3,78 €
+0,275 €
+7,85%
21.01.26
Depot/Watchlist
Marktkapitalisierung *
436,97 Mio. €
Streubesitz
32,19%
KGV
-0,53
Index-Zuordnung
-

DBV Technologies News

17.01.26 - GlobeNewswire
DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its ...
12.01.26 - GlobeNewswire
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total number of Voting Rights and  Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the ...
07.01.26 - GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated Information Châtillon, France, January 7, 2026 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN ...
05.01.26 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the ...
16.12.25 - GlobeNewswire
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Châtillon, France, December 16, 2025 DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children ...
02.12.25 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of November 30, 2025 (Article 223-16 of the General Regulations of the ...
12.11.25 - GlobeNewswire
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
Châtillon, France, November 11, 2025 DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN ® Peanut Patch in Peanut Allergic ...
04.11.25 - GlobeNewswire
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Châtillon, France, November 4, 2025 DBV Technologies to Participate in the Guggenheim 2 nd Annual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN ...
03.11.25 - GlobeNewswire
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
Chatillion, France, November 3, 2025 DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer DBV Technologies (Euronext: DBV – ISIN ...
03.11.25 - GlobeNewswire
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
Information Regarding the Total Number of Voting Rights and  Total Number of Shares of the Company as of October 31, 2025 (Article 223-16 of the General Regulations of the ...
30.10.25 - GlobeNewswire
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – ...
30.10.25 - GlobeNewswire
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
Châtillon, France, October 30, 2025 DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – ...
29.10.25 - GlobeNewswire
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Châtillon, France, October 29, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-​The-Market (ATM) Program on Nasdaq DBV ...
28.10.25 - GlobeNewswire
DBV Technologies Reports Third Quarter 2025 Financial Results
Châtillon, France, October 28, 2025 DBV Technologies Reports Third Quarter 2025 Financial Results DBV closes Q3 2025 with a cash and cash equivalents balance of $69.8 ...
06.10.25 - GlobeNewswire
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Châtillon, France, October 6, 2025
18.09.25 - GlobeNewswire
DBV Technologies Announces Resignation of Board Member
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market ...
05.09.25 - GlobeNewswire
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-​The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq ...
03.09.25 - GlobeNewswire
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27 th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN ...
01.08.25 - GlobeNewswire
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2025
29.07.25 - GlobeNewswire
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ...

Newssuche

Videos

newspaper
20.01.26 +5,12%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »